60 related articles for article (PubMed ID: 9759645)
1. Inhibitory effect of argatroban on thrombin-induced MAP kinase activation.
Hijikata-Okunomiya A; Nakaya Y; Takahashi A; Inoue N; Taniguchi T; Ishikawa Y
Thromb Haemost; 1998 Sep; 80(3):528-9. PubMed ID: 9759645
[No Abstract] [Full Text] [Related]
2. Effects of argatroban on thrombin-induced events in cultured vascular smooth muscle cells.
Hijikata-Okunomiya A; Nakaya Y; Inoue N; Takahashi A; Taniguchi T; Wanaka K; Tsuda Y; Okada Y; Ishikawa Y
Thromb Res; 2000 Feb; 97(4):257-62. PubMed ID: 10674413
[No Abstract] [Full Text] [Related]
3. Argatroban and inhibition of the vasomotor actions of thrombin.
Winn MJ; Jain K; Ku DD
J Cardiovasc Pharmacol; 1993 Nov; 22(5):754-60. PubMed ID: 7506329
[TBL] [Abstract][Full Text] [Related]
4. Severe decrease of cyclosporine levels in a heart transplant recipient receiving the direct thrombin inhibitor argatroban.
Sanchez R; Picard N; Mouly-Bandini A; Chalvignac V; Lacarelle B; Sampol-Manos E
Ther Drug Monit; 2014 Jun; 36(3):273-7. PubMed ID: 24365983
[TBL] [Abstract][Full Text] [Related]
5. Argatroban more effectively inhibits the thrombin activity in synovial fluid than naturally occurring thrombin inhibitors.
Asanuma K; Yoshikawa T; Yoshida K; Okamoto T; Asanuma Y; Hayashi T; Akita N; Oi T; Nishimura A; Hasegawa M; Sudo A
Cell Mol Biol (Noisy-le-grand); 2016 May; 62(6):27-32. PubMed ID: 27262798
[TBL] [Abstract][Full Text] [Related]
6. The thrombin inhibitor, argatroban, inhibits breast cancer metastasis to bone.
Asanuma K; Wakabayashi H; Okamoto T; Asanuma Y; Akita N; Yoshikawa T; Hayashi T; Matsumine A; Uchida A; Sudo A
Breast Cancer; 2013 Jul; 20(3):241-6. PubMed ID: 22359194
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effect of argatroban on thrombin-antithrombin III complex after percutaneous transluminal coronary angioplasty.
Sakamoto S; Hirase T; Suzuki S; Tsukamoto T; Miki T; Yamada T; Matsuo T
Thromb Haemost; 1995 Aug; 74(2):801-2. PubMed ID: 8585029
[No Abstract] [Full Text] [Related]
8. Effects of thrombin receptor activating peptide on phosphoinositide hydrolysis and protein kinase C activation in cultured rat aortic smooth muscle cells: evidence for "tethered-ligand" activation of smooth muscle cell thrombin receptors.
Webb ML; Taylor DS; Molloy CJ
Biochem Pharmacol; 1993 Apr; 45(8):1577-82. PubMed ID: 8387299
[TBL] [Abstract][Full Text] [Related]
9. ROCK mediates the inflammatory response in thrombin induced microglia.
Cui G; Zuo T; Zhao Q; Hu J; Jin P; Zhao H; Jing J; Zhu J; Chen H; Liu B; Hua F; Ye X
Neurosci Lett; 2013 Oct; 554():82-7. PubMed ID: 24021807
[TBL] [Abstract][Full Text] [Related]
10. Regulation of MAP-kinase activation by 8-iso-prostaglandin F2a in cultured rat aortic smooth muscle cells.
Fukunaga M; Yura T; Takahashi K; Badr KF
Adv Exp Med Biol; 1997; 433():193-6. PubMed ID: 9561133
[No Abstract] [Full Text] [Related]
11. A short synthesis of argatroban. a potent selective thrombin inhibitor.
Cossy J; Belotti D
Bioorg Med Chem Lett; 2001 Aug; 11(15):1989-92. PubMed ID: 11454464
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of thrombin-induced vascular endothelial growth factor production in human neuroblastoma (NB-1) cells by argatroban.
Sarker KP; Biswas KK; Yamaji K; Yamakuchi M; Hashiguchi T; Lee KY; Maruyama I
Pathophysiol Haemost Thromb; 2005; 34(1):41-7. PubMed ID: 16293985
[TBL] [Abstract][Full Text] [Related]
13. Thrombin inhibitor, argatroban, prevents tumor cell migration and bone metastasis.
Asanuma K; Wakabayashi H; Hayashi T; Okuyama N; Seto M; Matsumine A; Kusuzaki K; Suzuki K; Uchida A
Oncology; 2004; 67(2):166-73. PubMed ID: 15539922
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of inhibition by heparin of PDGF stimulated MAP kinase activation in vascular smooth muscle cells.
Pukac LA; Carter JE; Ottlinger ME; Karnovsky MJ
J Cell Physiol; 1997 Jul; 172(1):69-78. PubMed ID: 9207927
[TBL] [Abstract][Full Text] [Related]
15. The antithrombotic effect of low molecular weight synthetic thrombin inhibitors, argatroban and PPACK, on He-Ne laser-induced thrombosis in rat mesenteric microvessels.
Yamashita T; Yamamoto J; Sasaki Y; Matsuoka A
Thromb Res; 1993 Jan; 69(1):93-100. PubMed ID: 8465278
[TBL] [Abstract][Full Text] [Related]
16. Thrombin activates mitogen-activated protein kinase in primary astrocyte cultures.
Bhat NR; Zhang P; Hogan EL
J Cell Physiol; 1995 Nov; 165(2):417-24. PubMed ID: 7593220
[TBL] [Abstract][Full Text] [Related]
17. Effects of the synthetic thrombin inhibitor argatroban on fibrin- or clot-incorporated thrombin: comparison with heparin and recombinant Hirudin.
Berry CN; Girardot C; Lecoffre C; Lunven C
Thromb Haemost; 1994 Sep; 72(3):381-6. PubMed ID: 7855788
[TBL] [Abstract][Full Text] [Related]
18. Distinct inhibition by non-peptide and peptide arginine vasopressin antagonists of vasopressin-induced activation of mitogen-activated protein kinase in cultured rat vascular smooth muscle cells.
Okada K; Sasaki R; Ishikawa S; Saito T
Biochem Biophys Res Commun; 1994 Apr; 200(2):1155-60. PubMed ID: 8179597
[TBL] [Abstract][Full Text] [Related]
19. Aptamer-Based Enzyme Capture Assay for Measurement of Plasma Thrombin Levels.
Müller J; Becher T; Mayer G; Pötzsch B
Methods Mol Biol; 2016; 1380():179-89. PubMed ID: 26552826
[TBL] [Abstract][Full Text] [Related]
20. Inhibition by Argatroban, a specific thrombin inhibitor, of platelet activation by fibrin clot-associated thrombin.
Lunven C; Gauffeny C; Lecoffre C; O'Brien DP; Roome NO; Berry CN
Thromb Haemost; 1996 Jan; 75(1):154-60. PubMed ID: 8713795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
